Physician profile
Jason Green
NPI 1215000823
$1,121.69
in general payments reported to CMS, 2019-2025
17 companies · $71.01 in 2025
The $71.01 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2022: $27.69 · 2023: $41.57 · 2025: $71.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $143.65 | 2019 | |
| Vertiflex, INC. | $134.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $117.91 | 2019 | |
| Amgen INC. | $111.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $101.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $87.20 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.84 | 2019 | |
| Vanda Pharmaceuticals INC. | $69.26 | 2022-2023 | Hetlioz |
| Kowa Pharmaceuticals America, INC. | $56.31 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.06 | 2019 | |
| Abbvie INC. | $31.61 | 2019 | |
| Daiichi Sankyo INC. | $29.46 | 2019 | |
| Endo Pharmaceuticals INC. | $28.51 | 2019 | |
| Pfizer INC. | $27.30 | 2019 | |
| Bausch Health US, LLC | $19.73 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $19.37 | 2019 | |
| Lilly USA, LLC | $18.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.